BFC vs REGN · P/E 20, $1.59B cap vs P/E 14, rev $14.34B
Bank First National Corp (BFC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Bank First National Corp (BFC) is a banks - regional company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
BFC does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BFC currently screens at market cap $1.59B and trailing P/E 19.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BFC and REGN stock pages for the full models.
Not investment advice.